Ten AI denial management tools compared on what the AI actually does — predicting denials, drafting appeals, or autonomously working the denial queue.

10 Best AI Denial Management Tools (2026)

Quick answer: AI denial management tools apply artificial intelligence to denied claims — but they do very different jobs. Some predict denials before they happen, some auto-draft appeal letters, and some autonomously work the denial queue end to end. Honey Health leads for practices that want denials actually worked: an AI agent that tracks denials, drafts and submits appeals, and fixes the upstream causes. Waystar's AltitudeAI and Experian's AI Advantage bring generative drafting and denial prediction; Adonis, Thoughtful AI, Anomaly, and AKASA bring AI-native RCM; Rivet, Infinx, and FinThrive add AI to denial and underpayment recovery. The right pick depends on whether you want AI to predict, draft, or do the work.

Denials are a pattern problem, which is exactly why AI is being aimed at them. The reasons claims get denied are repetitive and learnable, the work of resolving them is procedural, and the volume is high — all the conditions under which modern AI does its best work. So it's no surprise that nearly every revenue-cycle vendor now markets AI denial management. The harder question is what the AI in each tool actually does, because "AI denial management" stretches across jobs that are not at all the same.

At least three distinct things travel under that label. Some AI predicts denials — scoring claims before submission for the likelihood they'll be rejected, so a person can fix them first. Some AI drafts — generating appeal letters and packages far faster than a human could assemble them. And some AI works the queue — autonomously diagnosing, correcting, resubmitting, appealing, and following up on denials with minimal human touch. A tool might do one of these brilliantly and the others not at all, so matching the AI's actual job to your actual bottleneck is the whole game.

This guide ranks the AI and AI-forward denial management tools in 2026, with a clear best-fit and an honest read on what each one's AI really does. It's the AI companion to our denial management software for medical billing guide, and it sits within the broader AI automation tools for medical practice operations pillar.

Last updated: June 2026.

Three jobs AI does in denial management

Sorting the tools by what their AI actually does is the fastest way to cut through the marketing. The first job is prediction. AI trained on historical claims and denials can score an outgoing claim for denial risk, or flag denials as they emerge, so the team intervenes before submission or prioritizes the most recoverable rejections. This is preventive and analytical — it tells you what's likely to go wrong, but a person still acts on it.

The second job is drafting. Generative AI can read a denial and the underlying claim and produce an appeal letter or package dramatically faster than manual assembly, compressing one of the most time-consuming steps in recovery. The third, and hardest, job is working the queue: an autonomous agent that takes a denial and runs it to resolution — diagnosing, correcting, resubmitting or appealing, and following up — escalating only the genuinely complex cases. Prediction reduces denials, drafting accelerates appeals, and autonomous working removes the labor entirely. The strongest tools combine more than one; the weakest claim "AI denial management" for a single narrow capability. Knowing which job you need keeps you from buying a predictor when your problem is a backlog no one has time to work.

How we evaluated AI denial management tools

Every tool here applies AI to denials, so we evaluated less on whether AI is present and more on what it does and how far it goes. The dimensions that separated them:

  • What the AI does — predict denials, draft appeals, or autonomously work the queue?
  • Autonomy — how much runs without staff, and how much is AI assisting a person?
  • Root-cause reach — does it connect denials to the eligibility, auth, and documentation causes that drive them?
  • AI type — an AI-native agent, or an established platform applying AI to denials?
  • Fit — focused denial tool, or denials within a broad AI RCM platform?

There's no universal winner, and the category is genuinely uneven in what its AI delivers, so each entry carries a clear best-fit and an honest note on what its AI does and doesn't do.

AI denial management tools at a glance

ToolBest forWhat the AI doesAutonomy
Honey HealthAutonomously working denialsWorks the queue + preventsHigh
Waystar (AltitudeAI)Generative appeal draftingDrafts + surfacesAssistive
Experian Health (AI Advantage)Denial predictionPredicts + surfacesAssistive
AdonisAI agents working denialsWorks the queueHigh
AnomalyAI payer + denial intelligencePredictsAssistive
Thoughtful AIAI RCM agentsWorks claims + denialsHigh
AKASAGenAI across the revenue cycleDrafts + assistsAssistive
RivetAI denials + underpaymentsSurfaces + assistsAssistive
InfinxAI + human denial recoveryWorks (AI + staff)Managed
FinThriveAI denial preventionPrevents + surfacesAssistive

The 10 best AI denial management tools in 2026

1. Honey Health — best for autonomously working denials

Honey Health applies AI to the hardest of the three jobs: actually working the denial queue. The company builds trained, dedicated AI workers that log into a practice's existing systems and run administrative workflows end to end, and denial management is a defined product. The technology is agentic browser automation — not rules-based RPA, not an API integration, not a browser extension. Each worker runs in a virtual browser, signs in with its own credentials, reads and understands the full screen, and operates the EHR, payer portals, and clearinghouse directly, adapting to popups and interface changes that break scripted bots; the founding team built anti-bot and automation systems at LinkedIn and Microsoft, where behaving like a real human user at scale was the whole problem.

Honey's AI tracks denials as they arrive, flags the top denial categories, and works the low- and mid-complexity denials end to end — drafting the appeal letter and submitting it — while providing a denial dashboard so the team can fix the upstream coding and submission problems. It does all three jobs rather than one: it surfaces and categorizes, it drafts and submits appeals, and it autonomously runs the resolution. And because Honey also runs eligibility verification, referral and authorization, and chart prep, its AI attacks the root causes that drive most denials — missing records, authorization gaps, eligibility errors — rather than only appealing after the fact. Honey reports 80 to 95 percent less manual effort, 99.8 to 99.9 percent task accuracy on a HIPAA-compliant and SOC 2 platform, go-live in two to three weeks, no onboarding fees, and a "needs human review" queue for the complex cases, backed by a dedicated human team.

The honest framing is that Honey autonomously works the low- and mid-complexity denials and escalates the most complex appeals to people, so it's the engine that clears the high-volume majority rather than a replacement for expert appellate judgment on the hardest cases. Pricing is per task, netting to roughly three to six dollars per hour of equivalent human work, with customers citing 2.91x savings per dollar. Where most AI here predicts denials or drafts appeals for a person to send, Honey's AI works the denial and fixes its cause. For a practice that wants denials genuinely worked by AI, it's the most complete option on this list.

2. Waystar — best for generative appeal drafting

Waystar has put generative AI at the center of its denial recovery through AltitudeAI, the AI layer of its end-to-end RCM platform. Its Denial + Appeal Management already used AI and predictive analytics to identify denials and focus on those most likely to be overturned; AltitudeAI adds generative drafting, and Waystar has reported that in its first months it made appeal-package creation roughly three times faster, saving meaningful time per appeal. Denials sit in the same platform as Waystar's eligibility, claims, and payment tools.

For AI denial management, Waystar's strength is that generative drafting capability inside a comprehensive, widely used platform: the AI compresses the most labor-intensive part of an appeal — assembling the package — while predictive analytics prioritize where to focus, all connected to the upstream work where denials originate. For an organization that wants AI-accelerated appeals inside a full RCM platform, it's a strong choice.

The honest framing is that Waystar's AI accelerates and prioritizes the appeal — drafting the package faster and pointing the team at the best targets — rather than fully autonomously working each denial without a person, and its value is realized as part of the broader platform. Best for organizations that want generative AI appeal drafting inside a full RCM platform.

3. Experian Health — best for denial prediction

Experian Health leads with the predictive job through its AI Advantage line, which applies machine learning to anticipate denials. Its two components — one that predicts which claims are likely to be denied before submission, and one that flags denials as they emerge and routes them by likelihood of being worked successfully — combine with its Denial Workflow Manager and the data depth of its parent company to put prevention at the center of denial strategy.

For AI denial management, Experian Health's strength is getting ahead of denials: predicting them before they happen lets a practice fix claims pre-submission, which is more valuable than appealing after the fact, and the emerging-denial triage focuses recovery where it'll pay off. For an organization that wants AI to reduce the denial rate, not just react to it, that predictive focus is distinctive.

The honest framing is that AI Advantage predicts and prioritizes — telling the team what's likely to be denied and what to work first — while the actual correction, appeal, and follow-up remain largely human tasks, and it's most powerful within a broader Experian Health deployment. Best for organizations that want AI denial prediction to get ahead of denials before they happen.

4. Adonis — best for AI agents working denials

Adonis is an AI-native RCM company whose agents autonomously execute high-friction revenue-cycle tasks, and working denials is central. Its AI agents handle denials and aging accounts-receivable follow-up — including agent-driven payer phone calls reported at a high success rate — and the company has cited reducing denial rates on impacted claims by more than half. Its platform also detects denial trends as they emerge and prioritizes claims by financial risk, pairing autonomous work with denial intelligence.

For AI denial management, Adonis's strength is genuine autonomous working: its agents pursue denials to resolution, even calling payers, rather than only predicting or drafting, and the trend detection and risk prioritization make that work smarter. For an organization modernizing its revenue cycle with autonomous AI agents, Adonis is a strong, focused fit.

The honest framing is that Adonis is a younger AI-native platform whose agents span the revenue cycle, so a buyer focused specifically on denials should confirm depth for their payer mix and denial types, and as with any agent, results depend on the workflows it's configured to run. Best for organizations that want AI agents autonomously working denials and A/R.

5. Anomaly — best for AI payer and denial intelligence

Anomaly describes itself as healthcare's first AI-powered payer-management company, applying AI to give providers payment certainty — predicting denials and payer behavior so organizations can anticipate and prevent the revenue loss denials cause. It raised an additional $17 million in 2026, bringing its total to $34 million, on the thesis that provider organizations lose enormous revenue to payer denials that better prediction could avert.

For AI denial management, Anomaly's strength is deep, AI-driven payer intelligence: by modeling how payers adjudicate and where denials originate, it helps practices get ahead of denials and understand the payer dynamics behind them, a focused, prediction-first approach from a well-funded specialist.

The honest framing is that Anomaly's center of gravity is prediction and payer intelligence — anticipating and preventing denials and underpayments — rather than autonomously working each appeal to resolution, so it pairs naturally with a working tool rather than replacing one. Best for organizations that want AI payer intelligence to predict and prevent denials.

6. Thoughtful AI — best for AI RCM agents

Thoughtful AI builds what it calls fully human-capable AI agents for healthcare revenue cycle management, deploying named agents — including CAM for claims processing — that perform RCM tasks autonomously. Having raised a $20 million Series A in July 2024, it positions its agents to handle the claims and denial-adjacent work that drives revenue, working across the systems a practice already uses.

For AI denial management, Thoughtful's strength is autonomous AI agents that work claims and the denial-related tasks around them as part of a connected RCM agent suite, so denial work sits alongside the eligibility and posting its other agents handle. For an organization that wants AI agents across the revenue cycle, including the claims work tied to denials, that unified approach is appealing.

The honest framing is that Thoughtful's agents center on claims processing and the broader RCM workflow, so a buyer focused specifically on end-to-end denial appeals should confirm how directly its agents draft and submit appeals versus working the surrounding claims tasks. Best for organizations that want AI RCM agents handling claims and denial-related work.

7. AKASA — best for GenAI across the revenue cycle

AKASA provides generative AI for the healthcare revenue cycle spanning prior authorization, clinical documentation integrity, coding, and claims management, serving more than 650 hospitals. Its GenAI platform is built to apply large-model intelligence across revenue-cycle work, and because denials so often stem from coding and documentation, its strengths in those areas connect directly to denial prevention and resolution.

For AI denial management, AKASA's strength is GenAI applied across the revenue cycle by a well-established, widely deployed vendor: improving the coding and documentation that prevent denials, and supporting the claims work where denials are resolved, with the credibility of a large hospital footprint. For a health system that wants generative AI across the whole revenue cycle, AKASA is a serious option.

The honest framing is that AKASA's center of gravity is coding, CDI, and claims rather than a dedicated denial-working engine, so its denial value comes through prevention and claims support more than autonomously drafting and submitting each appeal. Best for health systems that want GenAI across the revenue cycle, with denial prevention through better coding and documentation.

8. Rivet — best for AI denials plus underpayments

Rivet, based in Salt Lake City, is a modern revenue-accelerator platform whose Rivet Resolve denial management software pairs denial resolution with underpayment and payer-contract intelligence, increasingly supported by automation and analytics. Beyond denied claims, it surfaces claims underpaid relative to contract, alongside patient cost estimates and revenue diagnostics, in a cleaner interface than legacy tools.

For AI denial management, Rivet's strength is its dual focus on denials and underpayments with modern, analytics-driven tooling, so a practice recovers both denied claims and the revenue payers quietly shorted — a fuller view of leaked revenue, surfaced and prioritized intelligently. For a billing team that wants modern denial-and-underpayment recovery, Rivet is appealing.

The honest framing is that Rivet's strength is surfacing, prioritizing, and streamlining denial and underpayment recovery within a worklist a team still drives, rather than fully autonomous appeal generation and submission, and it's a focused revenue tool that pairs with rather than replaces a broad RCM system. Best for billing teams that want modern, analytics-driven denial and underpayment recovery.

9. Infinx — best for AI plus human denial recovery

Infinx pairs AI software with human expertise across patient access and revenue cycle, and denial management and A/R recovery are part of that surface. Its model combines AI-driven automation with a services layer of specialists who handle the exceptions, so denials are worked as a managed blend of software and trained people rather than as pure self-serve software.

For AI denial management, Infinx's strength is that the AI handles the routine denial volume while specialists work the complex appeals, which appeals to organizations that want recovered revenue as an outcome rather than a tool to operate — particularly those with complex payer mixes where denials are varied and exceptions common. The AI accelerates the routine; the human layer absorbs the hard cases.

The honest framing is that Infinx is partly a services company, so throughput depends on its staff as well as its automation, and organizations wanting fully autonomous software rather than an AI-plus-people service may find the model heavier. Best for organizations that want denial recovery delivered as AI-plus-human managed service.

10. FinThrive — best for AI denial prevention

FinThrive, formerly nThrive, applies analytics and intelligence to prevent denials from the front of the revenue cycle, arguing that denial management should start before the patient arrives. Across patient access, charge integrity, claims management, and contract management, it uses analytics to catch the eligibility and registration problems that cause denials upstream and to identify underpayments, framing AI and analytics as tools to reduce the denial rate rather than only react to it.

For AI denial management, FinThrive's strength is that prevention-first, analytics-driven philosophy on a broad RCM platform: by attacking denials at their upstream source and surfacing the patterns behind them, it reduces the denials a practice receives in the first place. For a health system that wants an upstream, analytics-led denial-prevention program, that strategy is compelling.

The honest framing is that FinThrive's AI and analytics center on prevention and visibility within a large platform, so they surface and reduce denials more than they autonomously work each appeal, and the value is realized as part of a broader FinThrive deployment. Best for health systems that want AI-driven denial prevention within a full RCM platform.

How to choose an AI denial management tool

Start by naming the job you need the AI to do, because the tools cluster around the three. If your problem is that too many claims get denied in the first place, prediction-first AI — Experian Health's AI Advantage, Anomaly, FinThrive's analytics — helps you get ahead of denials before they happen. If your appeals take too long to assemble, generative drafting like Waystar's AltitudeAI compresses that step. And if denials pile up faster than anyone can work them, you need AI that autonomously works the queue, which is where Honey Health, Adonis, and Thoughtful AI stand apart. Buying a predictor when your bottleneck is a backlog, or vice versa, is the most common and costliest mistake.

Then be precise about autonomy, because "AI" spans a wide range here. Some tools predict and hand off to staff; some draft a letter a person reviews and sends; some run the whole resolution and escalate only exceptions. The labor you save depends entirely on which of these the tool does, so press each vendor on exactly how much of the work happens without a person. The difference between AI that prioritizes your worklist and AI that empties it is enormous, and it's easy to blur in a demo.

Weigh root-cause reach, since the most durable denial reduction comes from fixing causes, not winning appeals. Denials overwhelmingly trace to upstream problems — eligibility, authorization, documentation — and AI that only works the denial after the fact treats the symptom. Tools whose AI also runs those upstream workflows, as Honey does by also handling eligibility, authorization, and records, or that predict and prevent, as Experian and FinThrive emphasize, reduce the denial rate itself rather than just recovering more of it.

Consider AI-native versus AI-enhanced and how it fits your stack. AI-native agents (Honey, Adonis, Thoughtful, Anomaly) and AI-plus-human services (Infinx) approach denials fresh and can do more autonomously; established platforms (Waystar, Experian Health, AKASA, Rivet, FinThrive) layer AI onto proven RCM infrastructure you may already run. The first can remove more labor; the second integrates with less change. For the full field including non-AI tools, see our denial management software guide; because eligibility drives denials, our AI eligibility and benefits verification tools guide is a useful companion; and for the wider back office, see the AI automation tools for medical practice operations pillar.

Frequently asked questions

What is AI denial management?

AI denial management applies artificial intelligence to denied claims, but the term covers several distinct jobs: predicting which claims will be denied before submission, generating appeal letters and packages, and autonomously working denials to resolution by diagnosing, correcting, resubmitting, appealing, and following up. A given tool may do one of these or several, so the key question is what its AI actually does.

What's the difference between AI that predicts, drafts, and works denials?

Prediction AI scores claims for denial risk or triages emerging denials, so a person can act — preventive, but it doesn't resolve anything itself. Drafting AI generates appeal letters far faster than manual assembly, accelerating one step of recovery. Working AI autonomously runs the whole resolution and escalates only the hard cases. Prediction reduces denials, drafting speeds appeals, and working removes the labor; Honey Health works the queue and also helps prevent.

Can AI fully resolve denials without staff?

For the low- and mid-complexity majority, increasingly yes. Autonomous agents like Honey Health and Adonis diagnose, correct, resubmit or appeal, and follow up on routine denials with minimal human touch, escalating the genuinely complex appeals to people. The hardest cases still benefit from human expertise and judgment, but the high-volume routine denials that consume most staff time can be worked autonomously.

Does AI denial management reduce the denial rate or just recover denials?

It depends on the tool. Recovery-focused AI helps collect denied revenue but doesn't necessarily stop denials recurring. Prediction and prevention AI — and tools that connect denials to upstream eligibility, authorization, and documentation causes — actually reduce the rate over time. The most complete approach does both: working the denials you have while fixing the causes so you receive fewer, which is why denial AI connects naturally to eligibility and authorization workflows.

How is AI denial management different from analytics dashboards?

Denial analytics surface and categorize denials so people can act; AI denial management can go further, predicting denials, generating appeals, or autonomously working them. Analytics tell you about your denials; the strongest AI does something about them. Many tools labeled "AI" are still primarily analytics, so it's worth confirming whether a tool reports on denials or actually resolves them.

How much do AI denial management tools cost?

Pricing varies by model. Autonomous agents like Honey Health charge per completed task, so cost scales with volume; AI-native RCM platforms (Adonis, Thoughtful AI, Anomaly) and AI-plus-human services (Infinx) price by deployment or as managed service; and AI features inside established platforms (Waystar, Experian Health, AKASA, Rivet, FinThrive) are typically part of platform pricing. Weigh any option against the denied and underpaid revenue currently written off.

AI denial management is real, but the label spans prediction, drafting, and autonomous working — three different jobs that solve three different bottlenecks. Decide which you need, press hard on how much the AI does without a person, and favor tools that also reach upstream to the causes, because the denial you prevent beats the one you recover. For a practice that wants denials genuinely worked by AI and their root causes fixed, Honey Health is the most complete place to begin.

More of our Article
CLINIC TYPE
LOCATION
INTEGRATIONS
More of our Article and Stories